Pressemitteilung: Velabs sichert EUR 3,0 Mio. in Serie B-Finanzierung (nur auf Englisch)

Xlife Sciences AG published this content on June 27, 2019, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 27, 2026 at 12:39 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]